Skip to content

Drug interactions

Cholera vaccine + Upadacitinib

Severity: Moderate

Cholera vaccine and Upadacitinib: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Upadacitinib may blunt the immune response to cholera vaccine, leaving the patient less protected. The oral cholera vaccine is live attenuated, so replication in an immunosuppressed host is a theoretical concern.

What this interaction means in plain words

Cholera vaccine and Upadacitinib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Evidence level: Low

Why it happens

Immunosuppression reduces vaccine immunogenicity and impairs control of live attenuated organisms.

What to do

Vaccinate at least 2 to 4 weeks before starting upadacitinib when possible. Otherwise confirm the response and consider alternative protective measures for travel.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Cholera vaccine and Upadacitinib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Cholera vaccine with Upadacitinib?

MediHelp rates the interaction as moderate. Cholera vaccine and Upadacitinib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Upadacitinib may blunt the immune response to cholera vaccine, leaving the patient less protected. The oral cholera vaccine is live attenuated, so replication in an immunosuppressed host is a theoretical concern.

How serious is the interaction between Cholera vaccine and Upadacitinib?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Vaccinate at least 2 to 4 weeks before starting upadacitinib when possible. Otherwise confirm the response and consider alternative protective measures for travel.

What other medicines interact with Upadacitinib?

MediHelp also lists interactions of Upadacitinib with, for example, Abrocitinib, Adenovirus types 4 and 7 live, Baricitinib. The full list is on the Upadacitinib page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in